XML 105 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Quarterly Financial Information (Unaudited) (Tables) - Revision of Prior Period, Adjustment [Member]
12 Months Ended
Dec. 31, 2023
Quarterly Financial Information (Unaudited) (Tables) [Line Items]  
Schedule of Condensed Consolidated Balance Sheets
 

AS RESTATED

   

3/31/2023

 

6/30/2023

 

9/30/2023

Assets

   

 

   

 

   

 

Cash and cash equivalents

 

97,811

 

 

20,880

 

 

92,722

 

Prepaid expense

 

102,980

 

 

52,885

 

 

27,550

 

Total current assets

 

200,791

 

 

73,765

 

 

120,272

 

     

 

   

 

   

 

Investments held in Trust Account

 

54,368,297

 

 

55,154,617

 

 

35,096,667

 

Total Assets

 

54,569,088

 

 

55,228,382

 

 

35,216,939

 

     

 

   

 

   

 

Liabilities, Redeemable Ordinary Shares and Stockholders’ Deficit

   

 

   

 

   

 

Accounts payable and accounts payable

 

3,584,797

 

 

3,853,954

 

 

3,976,694

 

Due to related party

 

265,000

 

 

331,826

 

 

258,966

 

Convertible promissory note – related party

 

1,000,000

 

 

1,000,000

 

 

1,000,000

 

Promissory Note – related party

 

250,000

 

 

250,000

 

 

250,000

 

Subscription liability, net of debt discount

 

251,880

 

 

467,274

 

 

1,060,112

 

Forward Purchase Agreement liability

 

633,205

 

 

 

 

 

Total current liabilities

 

5,984,882

 

 

5,903,054

 

 

6,545,772

 

     

 

   

 

   

 

Warrant liability

 

2,401,703

 

 

423,458

 

 

758,433

 

Total liabilities

 

8,386,585

 

 

6,326,512

 

 

7,304,205

 

     

 

   

 

   

 

Commitments and Contingencies

 
 

 

 
 

 

 
 

 

Class A Common Stock subject to possible redemption, 5,228,218, 5,228,218 and 3,255,593 shares at $10.40, $10.55 and $10.78 redemption value as of March 31, 2023, June 30, 2023 and September 30, 2023, respectively

 

54,368,296

 

 

55,154,617

 

 

35,096,667

 

     

 

   

 

   

 

Stockholders’ Deficit:

   

 

   

 

   

 

Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding

 

 

 

 

 

 

Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 0, 0 and 799 shares issued and outstanding (excluding 5,228,218, 5,228,218 and 3,255,593 shares subject to possible redemption) as of March 31, 2023, June 30, 2023 and September 30, 2023, respectively.

 

 

 

 

 

799

 

Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,980,409, 7,980,409 and 0 shares issued and outstanding as of March 31, 2023, June 30, 2023 and September 30, 2023.

 

799

 

 

799

 

 

 

Additional paid-in capital

 

7,531,767

 

 

6,912,413

 

 

6,319,277

 

Accumulated deficit

 

(15,718,359

)

 

(13,165,959

)

 

(13,504,009

)

Total stockholders’ deficit

 

(8,185,793

)

 

(6,252,747

)

 

(7,183,933

)

     

 

   

 

   

 

Total Liabilities, Redeemable Ordinary Shares and Stockholders’ Deficit

 

54,569,088

 

 

55,228,382

 

 

35,216,939

 

Schedule of Condensed Consolidated Statements of Operations
 

AS RESTATED

   

For the
three months
ended
March 31,
2023

 

For the
three months
ended
June 30,
2023

 

For the
six months
ended
June 30,
2023

 

For the
three months
ended
September 30,
2023

 

For the
nine months
ended
September 30, 2023

Formation and operating costs

 

$

1,153,282

 

 

$

578,954

 

 

$

1,732,236

 

 

$

353,372

 

 

$

2,085,609

 

Loss from operations

 

 

(1,153,282

)

 

 

(578,954

)

 

 

(1,732,236

)

 

 

(353,372

)

 

 

(2,085,609

)

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other (expense) income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrants liabilities

 

 

(2,022,486

)

 

 

1,978,245

 

 

 

(44,241

)

 

 

(334,975

)

 

 

(379,216

)

Change in fair value of Forward Purchase Agreement

 

 

(325,091

)

 

 

633,205

 

 

 

308,114

 

 

 

 

 

 

308,114

 

Issuance of Forward Purchase Agreement

 

 

(308,114

)

 

 

 

 

 

(308,114

)

 

 

 

 

 

(308,114

)

Reduction of deferred underwriter fee payable

 

 

328,474

 

 

 

 

 

 

328,474

 

 

 

 

 

 

328,474

 

Interest Expense – Debt Discount

 

 

(28,515

)

 

 

(106,416

)

 

 

(134,931

)

 

 

(279,013

)

 

 

(413,944

)

Interest income – trust account

 

 

3,088,967

 

 

 

626,320

 

 

 

3,715,287

 

 

 

629,310

 

 

 

4,344,597

 

Total other (expense) income, net

 

 

733,235

 

 

 

3,131,354

 

 

 

3,864,589

 

 

 

15,322

 

 

 

3,879,911

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(420,047

)

 

$

2,552,400

 

 

$

2,132,353

 

 

$

(338,050

)

 

$

1,794,302

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding, Class A ordinary shares subject to possible redemption

 

 

26,286,357

 

 

 

13,208,627

 

 

 

15,699,116

 

 

 

4,970,919

 

 

 

12,083,753

 

Basic and diluted net income per ordinary share, Class A ordinary shares subject to possible redemption

 

$

(0.01

)

 

$

0.12

 

 

$

0.09

 

 

$

(0.03

)

 

$

0.09

 

Weighted average shares outstanding, Class A ordinary shares subject to possible redemption

 

 

 

 

 

 

 

 

 

 

 

1,474,641

 

 

 

526,181

 

Basic and diluted net income per ordinary share, Class A ordinary shares

 

 

 

 

 

 

 

 

 

 

$

(0.03

)

 

$

0.09

 

Weighted average shares outstanding, Class B ordinary shares

 

 

7,980,409

 

 

 

7,980,409

 

 

 

7,980,409

 

 

 

6,505,768

 

 

 

7,454,228

 

Basic and diluted net income per ordinary share, Class B ordinary shares

 

$

(0.01

)

 

$

0.12

 

 

$

0.09

 

 

$

(0.03

)

 

$

0.09

 

Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit
 

Class A
ordinary shares

 

Class B
ordinary shares

 

Additional Paid-in
Capital

 

Accumulated
Deficit

 

Shareholders’
Deficit

   

Shares

 

Amount

 

Shares

 

Amount

 

Balance as of December 31, 2022

 

 

$

 

7,980,409

 

 

$

799

 

 

$

 

 

$

(15,298,312

)

 

$

(15,297,513

)

Reduction of deferred underwriter fees

     

 

     

 

 

 

 

 

 

 

10,844,098

 

 

 

 

 

 

 

10,844,098

 

Accretion of Class A ordinary shares to redemption value

     

 

     

 

 

 

 

 

 

 

(3,568,966

)

 

 

 

 

 

(3,568,966

)

Issuance of subscription shares

     

 

     

 

 

 

 

 

 

 

256,635

 

 

 

 

 

 

 

256,635

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(420,047

)

 

 

(420,047

)

Balance as of March 31, 2023 (As Restated)

 

 

$

 

7,980,409

 

 

$

799

 

 

$

7,531,767

 

 

$

(15,718,359

)

 

$

(8,185,793

)

Accretion of Class A ordinary shares to redemption value

     

 

     

 

 

 

 

 

 

 

(786,320

)

 

 

 

 

 

(786,320

)

Issuance of subscription shares

     

 

     

 

 

 

 

 

 

 

166,966

 

 

 

 

 

 

 

166,966

 

Net Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,552,400

 

 

 

2,552,400

 

Balance as of June 30, 2023 (As Restated)

 

 

$

 

7,980,409

 

 

$

799

 

 

$

6,912,413

 

 

$

(13,165,959

)

 

$

(6,252,747

)

Conversion of class B shares to Class A shares

 

7,980,409

 

 

799

 

(7,980,409

)

 

 

(799

)

 

 

 

 

 

 

 

 

 

 

 

Accretion of Class A ordinary shares to redemption value

     

 

     

 

 

 

 

 

 

 

(1,084,311

)

 

 

 

 

 

(1,084,311

)

Issuance of subscription shares

     

 

     

 

 

 

 

 

 

 

491,175

 

 

 

 

 

 

 

491,175

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(338,050

)

 

 

(338,050

)

Balance as of September 30, 2023 (As Restated)

 

7,980,409

 

$

799

 

 

 

$

 

 

$

6,319,277

 

 

$

(13,504,009

)

 

$

(7,183,933

)

Schedule of Condensed Consolidated Statements of Cash Flows
 

AS RESTATED

   

For the
three months
ended
March 31,
2023

 

For the
six months
ended
June 30,
2023

 

For the
nine months
ended
September 30,
2023

Cash flows from Operating Activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(420,048

)

 

$

2,132,353

 

 

$

1,794,302

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Interest earned on cash held in Trust Account

 

 

(3,088,966

)

 

 

(3,715,287

)

 

 

(4,344,597

)

Reduction of deferred underwriter fees

 

 

(328,474

)

 

 

(328,474

)

 

 

(328,474

)

Changes in fair value of warrant liabilities

 

 

2,022,486

 

 

 

44,241

 

 

 

379,216

 

Issuance of FPA

 

 

308,114

 

 

 

308,114

 

 

 

308,114

 

Change in fair value of FPA

 

 

325,091

 

 

 

(308,114

)

 

 

(308,114

)

Interest expense – debt discount

 

 

28,515

 

 

 

134,931

 

 

 

413,944

 

   

 

 

 

 

 

 

 

 

 

 

 

Prepaid assets

 

 

(59,349

)

 

 

(9,254

)

 

 

16,081

 

Due to related party

 

 

30,000

 

 

 

96,826

 

 

 

23,966

 

Accounts payable and accrued expenses

 

 

944,041

 

 

 

1,213,199

 

 

 

1,335,939

 

Net cash used in operating activities

 

 

(238,590

)

 

 

(431,465

)

 

 

(709,623

)

   

 

 

 

 

 

 

 

 

 

 

 

Cash flows from Investing Activities:

 

 

 

 

 

 

 

 

 

 

 

 

Extension payment deposit in Trust

 

 

(480,000

)

 

 

(640,000

)

 

 

(1,095,000

)

Cash withdrawn for redemptions

 

 

273,112,312

 

 

 

273,112,312

 

 

 

294,254,572

 

Net cash used in investing activities

 

 

272,632,312

 

 

 

272,472,312

 

 

 

293,159,572

 

   

 

 

 

 

 

 

 

 

 

 

 

Cash flows from Financing Activities:

 

 

 

 

 

 

 

 

 

 

 

 

Redemption of ordinary shares

 

 

(273,112,312

)

 

 

(273,112,312

)

 

 

(294,254,572

)

Proceeds from note payable-related party

 

 

250,000

 

 

 

250,000

 

 

 

250,000

 

Proceeds from subscription liability

 

 

480,000

 

 

 

755,944

 

 

 

1,560,944

 

Net cash provided by financing activities

 

 

(272,382,312

)

 

 

(272,106,368

)

 

 

(292,443,628

)

   

 

 

 

 

 

 

 

 

 

 

 

Net Change in Cash

 

 

11,410

 

 

 

(65,521

)

 

 

6,321

 

Cash, Beginning of period

 

 

86,401

 

 

 

86,401

 

 

 

86,401

 

Cash, End of period

 

$

97,811

 

 

$

20,880

 

 

$

92,722

 

Non-Cash investing and financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Accretion of Class A ordinary shares subject to possible redemption

 

$

3,568,966

 

 

$

4,355,287

 

 

$

5,439,596

 

Issuance of Subscription Shares

 

$

256,635

 

 

$

423,601

 

 

$

914,776